EGFR and neoplasm: We used a human epithelial non-small cell lung cancer (NSCLC) cell line with the well-characterized heterozygous epidermal growth factor receptor (EGFR) gene mutation T790M as a standardized tumor cell model with tyrosine kinase inhibitor resistance for generating liquid medium samples containing mutant sEVs.